Pharmosa Biopharm Inc
TPEX:6875
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharmosa Biopharm Inc
TPEX:6875
|
TW |
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
1
|
1CM Inc
F:IQ70
|
CA |
|
R
|
Raphas Co Ltd
KOSDAQ:214260
|
KR |
|
Robinhood Markets Inc
F:7KY
|
US |
|
C
|
Clara Industries Ltd
BSE:543435
|
IN |
|
Cowell Development Tbk PT
IDX:COWL
|
ID |
|
J
|
JPI Healthcare Co Ltd
KOSDAQ:0010V0
|
KR |
|
R
|
Richy Place 2002 PCL
SET:RICHY
|
TH |
|
CapitaLand Integrated Commercial Trust
OTC:CPAMF
|
SG |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
T
|
T-Robotics Co Ltd
KOSDAQ:117730
|
KR |
|
Currys PLC
OTC:CURYY
|
UK |
|
Character Group PLC
F:CG4
|
UK |
|
Phi Group Inc
OTC:PHIG
|
US |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
ID |
|
Kelso Technologies Inc
F:LB4A
|
CA |
|
I
|
Info-Tek Corp
TPEX:8183
|
TW |
|
H
|
Hannan Metals Ltd
SWB:C8MQ
|
CA |
Bankruptcy Probability
Pharmosa Biopharm Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pharmosa Biopharm Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
P
|
Pharmosa Biopharm Inc
TPEX:6875
|
3.4B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
503.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
98.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pharmosa Biopharm Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pharmosa Biopharm Inc has total debt of 321.4m TWD. This includes both short-term (0 TWD) and long-term (321.4m TWD) debt.
You can find a full breakdown on its Balance Sheet.